Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer.
Visseaux B, Gautier J, Le Boulaire F, Coignard C, Vincent C, Gréaume S, Voisin I, Lemée V, Plantier JC, Herpe YE, Brochot E, Bord S, Turini M, Roulet V, Hey J. Visseaux B, et al. Among authors: turini m. Pract Lab Med. 2024 Mar 15;39:e00390. doi: 10.1016/j.plabm.2024.e00390. eCollection 2024 Mar. Pract Lab Med. 2024. PMID: 38715659 Free PMC article.
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
Schwartzberg L, Navari RM, Ruddy KJ, LeBlanc TW, Clark-Snow R, Wickham R, Kloth D, Binder G, Bailey WL, Turini M, Potluri R, Liu X, Papademetriou E, Roeland EJ. Schwartzberg L, et al. Among authors: turini m. Support Care Cancer. 2023 Oct 25;31(12):654. doi: 10.1007/s00520-023-08119-1. Support Care Cancer. 2023. PMID: 37878086 Free PMC article.
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
Querfeld C, Nelson WW, Gor D, Pashos CL, Doan QV, Turini M, Angello JT, Geskin LJ. Querfeld C, et al. Among authors: turini m. Dermatol Ther (Heidelb). 2022 Dec;12(12):2781-2795. doi: 10.1007/s13555-022-00831-w. Epub 2022 Oct 25. Dermatol Ther (Heidelb). 2022. PMID: 36284059 Free PMC article.
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective.
Nilsson J, Piovesana V, Turini M, Lezzi C, Eriksson J, Aapro M. Nilsson J, et al. Among authors: turini m. Support Care Cancer. 2022 Nov;30(11):9307-9315. doi: 10.1007/s00520-022-07339-1. Epub 2022 Sep 8. Support Care Cancer. 2022. PMID: 36074186 Free PMC article.
Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis.
Botteman M, Nickel K, Corman S, Turini M, Binder G. Botteman M, et al. Among authors: turini m. Support Care Cancer. 2020 Feb;28(2):857-866. doi: 10.1007/s00520-019-04824-y. Epub 2019 Jun 3. Support Care Cancer. 2020. PMID: 31161436 Free PMC article.
Factors Associated with Breastfeeding Initiation and Continuation: A Meta-Analysis.
Cohen SS, Alexander DD, Krebs NF, Young BE, Cabana MD, Erdmann P, Hays NP, Bezold CP, Levin-Sparenberg E, Turini M, Saavedra JM. Cohen SS, et al. Among authors: turini m. J Pediatr. 2018 Dec;203:190-196.e21. doi: 10.1016/j.jpeds.2018.08.008. Epub 2018 Oct 4. J Pediatr. 2018. PMID: 30293638 Free article.
45 results